Intranasal GSK2245035 induces prolonged reductions in nasal responsiveness to allergen Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015
Impairment of leptin/leptin receptor pathway in nasal epithelium from allergic turbinates Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016
Influence of nebulized drugs on ciliary activity in vitro Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013
Evaluation of systemic exposure between two nasal spray formulations of mometasone furoate in healthy subjects Source: Annual Congress 2013 –Treatment of asthma Year: 2013
New inhaled JAK inhibitor LAS194046 inhibits allergen-induced airway inflammation in Brown Norway rats Source: International Congress 2014 – New drugs for asthma, COPD and pulmonary fibrosis Year: 2014
Fluticasone furoate maintains epithelial homeostasis via leptin/leptin receptor pathway in nasal cells Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013? Year: 2013
H4 receptor antagonits as a potential medication for upper airway cough syndrom Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014
QAV680, cetirizine and their combination reduce nasal symptoms in patients with intermittent allergic rhinitis in an environmental exposure chamber Source: International Congress 2014 – Allergy and asthma: novel findings based on human cell biology Year: 2014
Efficacy and safety of 10 day treatment with the CRTh2 antagonist QAV680 evaluated in patients with allergic rhinitis in an environmental exposure chamber Source: International Congress 2014 – Allergy and asthma: novel findings based on human cell biology Year: 2014
In vitro characterization of a novel inhaled PI3Kd inhibitor LAS194223Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014
In vitro profile of the new inhaled pan-JAK inhibitor LAS194046Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014
Expression of eotaxins in nasal mucosa of allergic patients after intranasal provocation- preliminary study Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013
Distribution of mast cells and their interactions with nerve in allergic rhinitis Source: International Congress 2015 – Asthma and lung immunology Year: 2015
A novel inhaled PI3Kδ inhibitor, LAS194223 reduces allergen-induced airway inflammation in rat Source: International Congress 2014 – New drugs for asthma, COPD and pulmonary fibrosis Year: 2014
Inhibitory effects of montelukast on mediator release by nasal epithelial cells from asthmatic subjects Source: Annual Congress 2013 –The pulmonary epithelium: recent developments Year: 2013
Inhibition of JAK/STAT pathway in airway epithelium as a potential targeted therapy of asthma Source: International Congress 2014 – New drugs for asthma, COPD and pulmonary fibrosis Year: 2014
New way forward in polyp research; changes in TLR9-expression of apparently healthy nasal mucosa behind polyp growth Source: Annual Congress 2013 –Studies of asthma in man Year: 2013
Comparison of three modalities of corticosteroids administration in chronic rhinosinusitis Source: International Congress 2014 – Novel evidence relating to respiratory treatment development Year: 2014
25-hydroxyvitamin D promotes the long-term effects of specific immunotherapy (SIT) in allergic airway inflammation in mice Source: International Congress 2014 – Animal models: asthma, COPD and beyond Year: 2014
RV-infection modifies DNA-methylation in nasal airway epithelium cell line: Evaluation as a possible asthma trigger Source: International Congress 2014 – Paediatric asthma: pathogenesis and immunology Year: 2014